electroCore, Inc. (ECOR)

NCM – Цена в реальном времени. Валюта: USD

7.84

+0.65 (9.04%)

При закрытии: Jun 26, 2026, 4:00 PM EDT

7.84

0.00 (0.00%)

После закрытия: Jun 26, 2026, 4:10 PM EDT

17.06.2026

electroCore to Participate in iAccess Alpha Virtual Best Ideas Summer Investment Conference

ROCKAWAY, N.J., June 17, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it will participate in the iAccess Alpha Virtual Best Ideas Summer Investment Conference on June 23-24, 2026.

09.06.2026

Frontiers in Neuroscience Accepts Review Article Synthesizing Evidence that Cervical nVNS Activates the Vagus Nerve Without Surgery

ROCKAWAY, N.J., June 09, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that the review article, "Without getting under your skin: non-invasive stimulation activates the vagus nerve," has been accepted for publication in Frontiers in Neuroscience.

02.06.2026

electroCore to Present at the Planet MicroCap Las Vegas 2026 Powered by MicroCapClub

ROCKAWAY, N.J., June 02, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be presenting at Planet MicroCap Las Vegas 2026 Powered by MicroCapClub being held at the Bellagio Resort & Casino in Las Vegas, NV. Joshua Lev, Interim President and CFO, will deliver a presentation and host one-on-one investor meetings throughout the conference.

19.05.2026

electroCore Touts 30% Growth Outlook, VA Opportunity at LD Micro Conference

electroCore NASDAQ: ECOR Interim President and CFO Joshua Lev said the bioelectronic technology company is focused on expanding its non-invasive vagus nerve stimulation platform across federal health care, commercial insurance channels and consumer wellness markets.

13.05.2026

electroCore Announces Publication in JAMA Highlighting the Benefits of Adding Quell Electrical Nerve Stimulation to Outpatient Physical Therapy in Fibromyalgia

ROCKAWAY, N.J., May 13, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today the publication of new clinical findings in JAMA Network Open titled, “Transcutaneous Electrical Nerve Stimulation and Pain With Movement in People With Fibromyalgia: A Cluster Randomized Clinical Trial.

09.05.2026

electroCore to Present at the LD Micro Invitational XVI Conference on May 18, 2026

ROCKAWAY, N.J., May 08, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be participating in the LD Micro Invitational XVI Conference being held at the Luxe Sunset Boulevard hotel in Los Angeles, CA. Joshua Lev, Interim President and CFO, will deliver a presentation and host one-on-one meetings throughout the day.

07.05.2026

electroCore, Inc. (ECOR) Q1 2026 Earnings Call Transcript

Видео

No Data

There is no data to display

Пресс-релизы

17.06.2026

electroCore to Participate in iAccess Alpha Virtual Best Ideas Summer Investment Conference

09.06.2026

Frontiers in Neuroscience Accepts Review Article Synthesizing Evidence that Cervical nVNS Activates the Vagus Nerve Without Surgery

13.05.2026

electroCore Announces Publication in JAMA Highlighting the Benefits of Adding Quell Electrical Nerve Stimulation to Outpatient Physical Therapy in Fibromyalgia

06.05.2026

electroCore Announces First Quarter 2026 Financial Results

First quarter 2026 net sales of $9.6 million, an increase of 43% over $6.7 million in the first quarter 2025 Net loss of $5.3 million with Adjusted EBITDA net loss improving 24% from prior-year period to $2.3 million Company to host a conference call and webcast today, May 6, 2026, at 4:30 pm EDT ROCKAWAY, N.J., May 06, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or the “Company”), a bioelectronic technology company, today announced financial results for the first quarter ended March 31, 2026.

electroCore, Inc. (ECOR)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

electroCore, Inc. (ECOR)

electroCore to Participate in iAccess Alpha Virtual Best Ideas Summer Investment Conference

Frontiers in Neuroscience Accepts Review Article Synthesizing Evidence that Cervical nVNS Activates the Vagus Nerve Without Surgery

electroCore to Present at the Planet MicroCap Las Vegas 2026 Powered by MicroCapClub

electroCore Touts 30% Growth Outlook, VA Opportunity at LD Micro Conference

electroCore Announces Publication in JAMA Highlighting the Benefits of Adding Quell Electrical Nerve Stimulation to Outpatient Physical Therapy in Fibromyalgia

electroCore to Present at the LD Micro Invitational XVI Conference on May 18, 2026

electroCore, Inc. (ECOR) Q1 2026 Earnings Call Transcript

Видео

No Data

Пресс-релизы

electroCore to Participate in iAccess Alpha Virtual Best Ideas Summer Investment Conference

Frontiers in Neuroscience Accepts Review Article Synthesizing Evidence that Cervical nVNS Activates the Vagus Nerve Without Surgery

electroCore Announces Publication in JAMA Highlighting the Benefits of Adding Quell Electrical Nerve Stimulation to Outpatient Physical Therapy in Fibromyalgia

electroCore Announces First Quarter 2026 Financial Results

electroCore to Participate in iAccess Alpha Virtual Best Ideas Summer Investment Conference

Frontiers in Neuroscience Accepts Review Article Synthesizing Evidence that Cervical nVNS Activates the Vagus Nerve Without Surgery

electroCore to Present at the Planet MicroCap Las Vegas 2026 Powered by MicroCapClub

electroCore Touts 30% Growth Outlook, VA Opportunity at LD Micro Conference

electroCore Announces Publication in JAMA Highlighting the Benefits of Adding Quell Electrical Nerve Stimulation to Outpatient Physical Therapy in Fibromyalgia

electroCore to Present at the LD Micro Invitational XVI Conference on May 18, 2026

electroCore, Inc. (ECOR) Q1 2026 Earnings Call Transcript

Видео

No Data

Пресс-релизы

electroCore to Participate in iAccess Alpha Virtual Best Ideas Summer Investment Conference

Frontiers in Neuroscience Accepts Review Article Synthesizing Evidence that Cervical nVNS Activates the Vagus Nerve Without Surgery

electroCore Announces Publication in JAMA Highlighting the Benefits of Adding Quell Electrical Nerve Stimulation to Outpatient Physical Therapy in Fibromyalgia

electroCore Announces First Quarter 2026 Financial Results

Search stocks

electroCore, Inc. (ECOR)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

electroCore, Inc. (ECOR)

electroCore to Participate in iAccess Alpha Virtual Best Ideas Summer Investment Conference

Frontiers in Neuroscience Accepts Review Article Synthesizing Evidence that Cervical nVNS Activates the Vagus Nerve Without Surgery

electroCore to Present at the Planet MicroCap Las Vegas 2026 Powered by MicroCapClub

electroCore Touts 30% Growth Outlook, VA Opportunity at LD Micro Conference

electroCore Announces Publication in JAMA Highlighting the Benefits of Adding Quell Electrical Nerve Stimulation to Outpatient Physical Therapy in Fibromyalgia

electroCore to Present at the LD Micro Invitational XVI Conference on May 18, 2026

electroCore, Inc. (ECOR) Q1 2026 Earnings Call Transcript

Видео

No Data

Пресс-релизы

electroCore to Participate in iAccess Alpha Virtual Best Ideas Summer Investment Conference

Frontiers in Neuroscience Accepts Review Article Synthesizing Evidence that Cervical nVNS Activates the Vagus Nerve Without Surgery

electroCore Announces Publication in JAMA Highlighting the Benefits of Adding Quell Electrical Nerve Stimulation to Outpatient Physical Therapy in Fibromyalgia

electroCore Announces First Quarter 2026 Financial Results

electroCore to Participate in iAccess Alpha Virtual Best Ideas Summer Investment Conference

Frontiers in Neuroscience Accepts Review Article Synthesizing Evidence that Cervical nVNS Activates the Vagus Nerve Without Surgery

electroCore to Present at the Planet MicroCap Las Vegas 2026 Powered by MicroCapClub

electroCore Touts 30% Growth Outlook, VA Opportunity at LD Micro Conference

electroCore Announces Publication in JAMA Highlighting the Benefits of Adding Quell Electrical Nerve Stimulation to Outpatient Physical Therapy in Fibromyalgia

electroCore to Present at the LD Micro Invitational XVI Conference on May 18, 2026

electroCore, Inc. (ECOR) Q1 2026 Earnings Call Transcript

Видео

No Data

Пресс-релизы

electroCore to Participate in iAccess Alpha Virtual Best Ideas Summer Investment Conference

Frontiers in Neuroscience Accepts Review Article Synthesizing Evidence that Cervical nVNS Activates the Vagus Nerve Without Surgery

electroCore Announces Publication in JAMA Highlighting the Benefits of Adding Quell Electrical Nerve Stimulation to Outpatient Physical Therapy in Fibromyalgia

electroCore Announces First Quarter 2026 Financial Results